Adial Pharmaceuticals, Inc. (ADIL)

4.28

-0.03 (-0.70%)

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-565

-564

Gross Profit

-565

-564

Operating expenses (excl. COGS)

-8M

-7M

-11M

Operating Income

-8M

-7M

-11M

Non-operating income, total

-178K

-5M

-114K

585K

Pretax income

-8M

-13M

-7M

-11M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-8M

-13M

-7M

-11M

Discontinued operations

-746K

-2M

Net income

-8M

-13M

-8M

-13M

Dilution adjustment

Preferred dividends

Adial Pharmaceuticals, Inc. (ADIL)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Adial Pharmaceuticals, Inc. (ADIL)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Adial Pharmaceuticals, Inc. (ADIL)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Adial Pharmaceuticals, Inc. (ADIL)

Income Statement (Annual)

Income Statement (Annual)